News
| Feb 03 | Three different after-hours purchases of 1000+ shares at $11.73... odd $ACHN by jckund |
| Feb 03 | $SODA $DNDN $VRTX $ACHN $CLDX $IDIX Holding long, Great upside opp.....Patience, Patience.....Have GREAT weekend....Go Pats...!! by ByHighSellHigher |
| Feb 03 | @EXPstocktrader. Thanks for a great week. Will be back next week. You really are awesome. Hopefully we hear good news on $IDIX, $ACHN on wkn by newbtrader |
| Feb 03 | $ACHN broke down out of shelf, could be MM loading up? by kkess003 |
| Feb 03 | $idix yeah!!!!!!!!!!!!! going to dip into $achn i wanted to avoid for a while but missed yesterdays gains by PeruvianKnightmare |
| Feb 03 | $ACHN Just need a lil volume by kkess003 |
| Feb 03 | Short $IDIX as pair with Long $ACHN by stoneoak79 |
| Feb 03 | Mark my words $ACHN will blow thru $12 before the EOD....lets see it by EXPstocktrader |
| Feb 03 | $OCZ blasting off. On the launch pad... $ONTY $SINO $ACHN $CLDX by contrarian1 |
| Feb 03 | $ACHN picking up toward the final hour.........hopefully news of $VRTX offer to buy them is real and will consumate soon! by taketheplunge |
| Feb 03 | Morning Movers 02/03: (THLD) (ZOLT) (HPOL) (MOTR) Higher; (PCCC) (STRI) (SMT) Lower Street Insider |
| Feb 03 | Gilead (GILD) Issues Strong '7977 Update, Shares Move Higher Street Insider |
| Feb 03 | Pre-market top 5 losers |
| Feb 03 | Achillion Announces Executive Promotion GlobeNewswire |
| Feb 02 | Gilead Gains on Positive Data From Experimental Hepatitis C Drug |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Achillion Pharmaceuticals is up N/A over the last year vs S&P 500 Total Return up N/A, BioLineRx up N/A, and Idenix Pharmaceuticals up N/A.
- ACHN Total Returns
- ^SPXTR Total Returns
- BLRX Total Returns
- IDIX Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ACHN related companies
Pro Strategies Featuring ACHN
Did Achillion Pharmaceuticals make it into our Pro Portfolio Strategies?
ACHN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other ACHN Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACHN | 11.73 | -0.65 | -5.21% | 817.82M |
| CME | 273.43 | 7.42 | 2.79% | 18.28B |
| ANR | 22.78 | 1.14 | 5.27% | 5.16B |
| ITRI | 39.79 | 1.40 | 3.65% | 1.62B |
| TGT | 52.14 | 0.14 | 0.27% | 35.21B |
| AIG | 27.17 | 0.86 | 3.27% | 51.57B |
| AXP | 52.25 | 1.09 | 2.13% | 60.69B |
| JBLU | 6.23 | 0.14 | 2.38% | 1.85B |
| HA | 6.59 | 0.20 | 3.13% | 334.18M |
| ES | 4.08 | 0.15 | 3.82% | 362.22M |
